Patent · US Active

Separation of protactinum, actinium, and other radionuclides from proton irradiated thorium target

US9951399B2 · kind B2 · utility

1Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 8, 2015
Grant dateApr 24, 2018
Priority date
Expiry dateJul 31, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P10/20
  • WIPO fieldMaterials, metallurgy
  • WIPO sectorChemistry

Abstract

Protactinium, actinium, radium, radiolanthanides and other radionuclide fission products were separated and recovered from a proton-irradiated thorium target. The target was dissolved in concentrated HCl, which formed anionic complexes of protactinium but not with thorium, actinium, radium, or radiolanthanides. Protactinium was separated from soluble thorium by loading a concentrated HCl solution of the target onto a column of strongly basic anion exchanger resin and eluting with concentrated HCl. Actinium, radium and radiolanthanides elute with thorium. The protactinium that is retained on the column, along with other radionuclides, is eluted may subsequently treated to remove radionuclide impurities to afford a fraction of substantially pure protactinium. The eluate with the soluble thorium, actinium, radium and radiolanthanides may be subjected to treatment with citric acid to form anionic thorium, loaded onto a cationic exchanger resin, and eluted. Actinium, radium and radiolanthanides that are retained can be subjected to extraction chromatography to separate the actinium from the radium and from the radio lanthanides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.